Cholinergic Modulation of Locomotion and Striatal Dopamine Release Is Mediated by 6 4* Nicotinic Acetylcholine Receptors
Open accessAbstract
Dopamine (DA) release in striatum is governed by firing rates of midbrain DA neurons, striatal cholinergic tone, and nicotinic ACh receptors (nAChRs) on DA presynaptic terminals. DA neurons selectively express alpha6* nAChRs, which show high ACh and nicotine sensitivity. To help identify nAChR subtypes that control DA transmission, we studied transgenic mice expressing hypersensitive alpha6(L9'S)* receptors. alpha6(L9'S) mice are hyperactive, travel greater distance, exhibit increased ambulatory behaviors such as walking, turning, and rearing, and show decreased pausing, hanging, drinking, and grooming. These effects were mediated by alpha6alpha4* pentamers, as alpha6(L9'S) mice lacking alpha4 subunits displayed essentially normal behavior. In alpha6(L9'S) mice, receptor numbers are normal, but loss of alpha4 subunits leads to fewer and less sensitive alpha6* receptors. Gain-of-function nicotine-stimulated DA release from striatal synaptosomes requires alpha4 subunits, implicating alpha6alpha4beta2* nAChRs in alpha6(L9'S) mouse behaviors. In brain slices, we applied electrochemical measurements to study control of DA release by alpha6(L9'S) nAChRs. Burst stimulation of DA fibers elicited increased DA release relative to single action potentials selectively in alpha6(L9'S), but not WT or alpha4KO/alpha6(L9'S), mice. Thus, increased nAChR activity, like decreased activity, leads to enhanced extracellular DA release during phasic firing. Bursts may directly enhance DA release from alpha6(L9'S) presynaptic terminals, as there was no difference in striatal DA receptor numbers or DA transporter levels or function in vitro. These results implicate alpha6alpha4beta2* nAChRs in cholinergic control of DA transmission, and strongly suggest that these receptors are candidate drug targets for disorders involving the DA system.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Expression of a hypersensitive α6 subunit in a BAC transgenic mouse line potentiates nicotine-induced burst firing in DA neurons and potentiates nicotine place preference at low doses.
“Similarly, expression of a hypersensitive α6 subunit in a bacterial artificial chromosome (BAC) transgenic mouse line potentiates nicotine-induced burst firing in DA neurons, and potentiates nicotine place preference at low doses of nicotine (Drenan et al. 2008a(Drenan et al. , 2010)).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Drenan et al. 2010
The Results (α6α4* nAChR-mediated locomotion and behavioral analysis; page unavailable) identify the hypersensitive α6L9′S BAC mouse line. The Results (Burst firing selectively increases DA release in α6L9′S dorsal striatum; page unavailable) report that nicotine increases DA-neuron firing, but only suggest that it may increase burst firing. Our copy does not report nicotine place preference at low doses; its low-dose behavioral finding concerns locomotor activation. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Midbrain dopamine neurons encode a quantitative reward prediction error signal
Bayer, H. M., & Glimcher, P. W. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.020 · Cited by 1,304 · see citing works
Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G. D., Bonci, A., de Lecea, L., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1168878 · Cited by 1,266 · see citing works
Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., & Roeper, J. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.022 · Cited by 976 · see citing works
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · see citing works
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · see citing works
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585 · see citing works
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 2× · see citing works
“2 subunits are strictly required for nAChR function in midbrain DA neurons (Picciotto et al., 1998; Maskos et al., 2005); 4 subunits are expressed in nearly all DA neurons, and loss of 4 subunits eliminates 80% of surface nAChRs in these cells (Azam et al.”
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works
Self-citationHyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 493 · see citing works
A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489 · see citing works
Self-citationFiring modes of midbrain dopamine cells in the freely moving rat
Hyland, B. I., Reynolds, J. N. J., HAY, J. G., Perk, C. G., & Miller, R. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00267-1 · Cited by 487 · see citing works
Axon Initial Segment Kv1 Channels Control Axonal Action Potential Waveform and Synaptic Efficacy
Kole, M. H. P., Letzkus, J. J., & Stuart, G. J. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.031 · Cited by 452 · see citing works
Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426 · see citing works
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works
Self-citationModulation of intracortical synaptic potentials by presynaptic somatic membrane potential
Shu, Y., Hasenstaub, A. R., Duque, A., Yu, Y., & McCormick, D. A. (2006) · Nature · doi:10.1038/nature04720 · Cited by 397 · see citing works
Frequency-dependent modulation of dopamine release by nicotine
Zhang, H., & Sulzer, D. (2004) · Nature Neuroscience · doi:10.1038/nn1243 · Cited by 361 · see citing works
Champtiaux, N., Han, Z., Bessis, A., Rossi, F., Zoli, M., Marubio, L. M., McIntosh, J. M., & Changeux, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345 · see citing works
Self-citationRice, M. E., & Cragg, S. J. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.004 · Cited by 340 · see citing works
Labarca, C. G., Nowak, M. W., Zhang, H., Tang, L., Deshpande, P., & Lester, H. A. (1995) · Nature · doi:10.1038/376514a0 · Cited by 302 · see citing works
Self-citationNashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · see citing works
Self-citationAzam, L., Winzer‐Serhan, U. H., Chen, Y.-L., & Leslie, F. M. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10138 · Cited by 258 · see citing works
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 249 · see citing works
Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242 · see citing works
Self-citationExley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · see citing works
Self-citationChergui, K., Suaud‐Chagny, M., & Gonon, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90465-0 · Cited by 229 · see citing works
Threlfell, S., Clements, M. A., Khodai, T., Pienaar, I. S., Exley, R. A., Wess, J., & Cragg, S. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5620-09.2010 · Cited by 224 · see citing works
Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213 · see citing works
Self-citationRoss, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204 · see citing works
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197 · see citing works
Self-citationCorelease of Dopamine and Serotonin from Striatal Dopamine Terminals
Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., Biasi, M. D., & Dani, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.010 · Cited by 187 · see citing works
Steele, A. D., Jackson, W. S., King, O. D., & Lindquist, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610779104 · Cited by 181 · see citing works
Self-citationAltered Dopamine Release and Uptake Kinetics in Mice Lacking D2Receptors
Schmitz, Y., Schmauss, C., & Sulzer, D. L. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08002.2002 · Cited by 176 · see citing works
Electrochemical monitoring of biogenic amine neurotransmission in real time
Michael, D. J., & Wightman, R. M. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00145-9 · Cited by 173 · see citing works
Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine
Zhang, T., Zhang, L., Liang, Y., Siapas, A. G., Zhou, F.-M., & Dani, J. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0261-09.2009 · Cited by 165 · see citing works
Senior, S. L., Ninkina, N. N., Deacon, R. M. J., Bannerman, D. M., Buchman, V. L., Cragg, S. J., & Wade‐Martins, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06055.x · Cited by 164 · see citing works
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works
Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 149 · see citing works
Self-citationCragg, S. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04378.2003 · Cited by 138 · see citing works
Schulte, A., & Chow, R. H.-P. (1996) · Analytical Chemistry · doi:10.1021/ac960210n · Cited by 134 · see citing works
Gotti, C., Moretti, M., Clementi, F., Riganti, L., McIntosh, J. M., Collins, A. C., Marks, M. J., & Whiteaker, P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011940 · Cited by 133 · see citing works
Self-citationStriatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works
Self-citationLança, A. J., Adamson, K. L., Coen, K. M., Chow, B. L., & Corrigall, W. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00607-7 · Cited by 120 · see citing works
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 115 · see citing works
Self-citationGrady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.651 · Cited by 110 · see citing works
Self-citationDrenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Self-citationBrown, R. W. B., Collins, A. C., Lindstrom, J. M., & Whiteaker, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04700.x · Cited by 88 · cited 1× · see citing works
“Previously published methods (Marks et al., 2006; Brown et al., 2007) were followed to measure high-affinity [ 125I]epibatidine (2200 Ci/ mmol) binding to membrane preparations using a 96-well plate format.”
MethodNeuronal and astrocyte expression of nicotinic receptor subunit β4 in the adult mouse brain
Gahring, L. C., Persiyanov, K., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10942 · Cited by 86 · see citing works
Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization
Bordia, T., Campos, C., McIntosh, J. M., & Quik, M. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162396 · Cited by 82 · cited 2× · see citing works
“For example, stimulating DA release with α6α4β2* selective compounds in PD may alleviate dyskinesias associated with LDopa therapy if co-administration of the nAChR compound allowed the clinician to reduce the necessary dose of L-Dopa (Quik and McIntosh, 2006; Quik et al., 2008; Bordia et al., 2010).”
Self-citationHeat shock factor 1 regulates lifespan as distinct from disease onset in prion disease
Steele, A. D., Hütter, G., Jackson, W. S., Heppner, F. L., Borkowski, A. W., King, O. D., Raymond, G. J., Aguzzi, A., & Lindquist, S. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806319105 · Cited by 67 · see citing works
Self-citationSalminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63 · see citing works
Self-citationMarks, M. J., Whiteaker, P., & Collins, A. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025338 · Cited by 53 · see citing works
Self-citationTapper, A. R., McKinney, S. L., Marks, M. J., & Lester, H. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00063.2007 · Cited by 40 · see citing works
Self-citationParish, C. L., Nunan, J., Finkelstein, D. I., McNamara, F. N., Wong, J. Y. F., Waddington, J. L., Brown, R. M., Lawrence, A. J., Horne, M. K., & Drago, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004820 · Cited by 38 · see citing works
Akopian, G. K., Crawford, C. A., Beal, M. F., Cappelletti, M., Jakowec, M. W., Petzinger, G. M., Zheng, L., Gheorghe, S. L., Reichel, C. M., Chow, R. H.-P., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5698-07.2008 · Cited by 26 · see citing works
Huang, C., Chen, H., Huang, N., Yang, D., Kao, L., Chen, J., Lai, H., & Chern, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722437.x · Cited by 19 · see citing works
Hyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Routledge eBooks · doi:10.4324/9781315054315-17 · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · see citing works
“In the midbrain, nAChRs comprising the β2 nAChR subunit in combination with α4 and/or α6 subunits are essential for nicotine-induced reinforcement and the DA signal (Drenan et al. 2010, Mameli-Engvall et al. 2006, Picciotto et al. 1998, Pons et al. 2008, Tapper et al. 2004).”
BackgroundDopamine Signaling in Dorsal Versus Ventral Striatum: The Dynamic Role of Cholinergic Interneurons
Threlfell, S., & Cragg, S. J. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00011 · Cited by 195 · see citing works
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 178 · see citing works
How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?
McKee, S. A., & Weinberger, A. H. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 160 · see citing works
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · see citing works
Self-citationMechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 157 · see citing works
Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125 · see citing works
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 123 · see citing works
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 126 · see citing works
Dopaminergic and cholinergic learning mechanisms in nicotine addiction
Subramaniyan, M., & Dani, J. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12871 · Cited by 103 · see citing works
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97 · see citing works
Guzmán, M. S., Jaeger, X. D., Raulic, S., Souza, I. A., Li, A. X., Schmid, S., Menon, R. S., Gainetdinov, R. R., Caron, M. G., Bartha, R., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001194 · Cited by 94 · see citing works
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works
Self-citationFunctional roles of neurotransmitters and neuromodulators in the dorsal striatumPreprint
Do, J., Kim, J., Bakes, J., Lee, K., & Kaang, B. (2012) · Learning & Memory · doi:10.1101/lm.025015.111 · Cited by 75 · see citing works
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4 subtype
Hone, A. J., Meyer, E. L., McIntyre, M., & McIntosh, J. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-195883 · Cited by 76 · see citing works
Self-citationSanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 71 · see citing works
Self-citationNair, A. G., Gutierrez‐Arenas, O., Eriksson, O., Vincent, P., & Kotaleski, J. H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-15.2015 · Cited by 69 · see citing works
Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine
Wang, L., Shang, S., Kang, X., Teng, S., Zhu, F., Liu, B., Wu, Q., Li, M., Liu, W. Y., Xu, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4925 · Cited by 68 · see citing works
α6* Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience Circuit
Mackey, E. D. W., Engle, S. E., Kim, M. R., O’Neill, H. C., Wageman, C. R., Patzlaff, N. E., Wang, Y., Grady, S. R., McIntosh, J. M., Marks, M. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0007-12.2012 · Cited by 63 · see citing works
Self-citationDirect and GABA‐mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones
Luo, R., Janssen, M. J., Partridge, J. G., & Vicini, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241786 · Cited by 62 · see citing works
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58 · see citing works
Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 59 · see citing works
Buck, J. M., Sanders, K. N., Wageman, C., Knopik, V., Stitzel, J., & O’Neill, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.006 · Cited by 49 · see citing works
Avelar, A. J., Akers, A. T., Baumgard, Z. J., Cooper, S. Y., Casinelli, G. P., & Henderson, B. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107729 · Cited by 56 · see citing works
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 54 · see citing works
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 53 · see citing works
Melatonin Protects Against Diazinon-Induced Neurobehavioral Changes in Rats
Ahmed, M. A. E., Ahmed, H. I., & Morsy, E. M. E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1134-9 · Cited by 51 · see citing works
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 51 · see citing works
Self-citationEngle, S. E., Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087346 · Cited by 51 · see citing works
Self-citationAnderson, S. M., & Brunzell, D. H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13090 · Cited by 50 · see citing works
Powers, M. S., Broderick, H. J., Drenan, R. M., & Chester, J. A. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12042 · Cited by 49 · see citing works
Self-citationNicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior
Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 47 · see citing works
Self-citationLRRK 2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
Liu, H., Song, L., Ho, P. W., Tse, H., Pang, S. Y., Kung, M. H.-W., Ho, J. W.-M., Ramsden, D. B., Zhou, Z., & Ho, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.45 · Cited by 43 · see citing works
Schilaty, N. D., Hedges, D. M., Jang, E. Y., Folsom, R. J., Yorgason, J. T., McIntosh, J. M., & Steffensen, S. C. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211490 · Cited by 42 · see citing works
Self-citationBrunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 40 · see citing works
Self-citationProgress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 39 · see citing works
Nicotinic Receptor Subtype-Selective Circuit Patterns in the Subthalamic Nucleus
Xiao, C., Miwa, J. M., Henderson, B. J., Wang, Y., Deshpande, P., McKinney, S. L., & Lester, H. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3528-14.2015 · Cited by 39 · see citing works
Self-citationGarção, P., Szabó, E. C., Wopereis, S., de Castro, A. A., Tomé, Â. R., Prediger, R. D., Cunha, R. A., Agostinho, P. M., & Köfalvi, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12234 · Cited by 39 · see citing works
Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release
Acevedo-Rodriguez, A., Zhang, L., Zhou, F., Gong, S., Gu, H. H., Biasi, M. D., Zhou, F.-M., & Dani, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00019 · Cited by 35 · see citing works
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Quik, M., Boyd, J. T., Bordia, T., & Perez, X. A. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty063 · Cited by 38 · see citing works
Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37 · see citing works
Self-citationWickham, R. J., Solecki, W., Rathbun, L. R., McIntosh, J. M., & Addy, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3082-0 · Cited by 35 · see citing works
Self-citationCahir, E., Pillidge, K., Drago, J., & Lawrence, A. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.35 · Cited by 36 · see citing works
Neurochemical organization of the ventral striatum’s olfactory tubercle
Cansler, H. L., Wright, K. N., Stetzik, L. A., & Wesson, D. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14919 · Cited by 34 · see citing works
Cooper, S. Y., Akers, A. T., & Henderson, B. J. (2020) · eNeuro · doi:10.1523/eneuro.0172-20.2020 · Cited by 35 · see citing works
Mesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34 · see citing works
Levin, E. D., Hao, I., Burke, D. A., Cauley, M. C., Hall, B. J., & Rezvani, A. H. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543721 · Cited by 34 · see citing works
Zlomuzica, A., Viggiano, D., Degen, J., Binder, S., Ruocco, L. A., Sadile, A. G., Willecke, K., Huston, J. P., & Dere, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.028 · Cited by 34 · see citing works
Richter, F., Gao, F., Medvedeva, V. P., Lee, P. C., Bove, N., Fleming, S. M., Michaud, M., Lemesre, V., Patassini, S., Rosa, K. D. L., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.012 · Cited by 33 · see citing works
Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.014 · Cited by 33 · see citing works
Self-citationBrunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 32 · see citing works
Weinstein‐Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Moshe Szyf, A., & Ornoy, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215278 · Cited by 31 · see citing works
Berry, J. N., Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.052 · Cited by 30 · see citing works
Self-citationCholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30 · see citing works
Enhanced synthesis and release of dopamine in transgenic mice with gain‐of‐function α6* nAChR s
Wang, Y., Lee, J., Oh, G., Grady, S. R., McIntosh, J. M., Brunzell, D. H., Cannon, J. R., & Drenan, R. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12616 · Cited by 29 · see citing works
Self-citationAlpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 29 · see citing works
Self-citationCholinergic system in schizophrenia: A systematic review and meta-analysis
Saint-Georges, Z., MacDonald, J., Al-Khalili, R., Hamati, R., Solmi, M., Keshavan, M. S., Tuominen, L. J., & Guimond, S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03023-y · Cited by 30 · see citing works
Lian, M., Hueffer, K., & Weltzin, M. M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10434 · Cited by 33 · see citing works
Utility of genetically modified mice for understanding the neurobiology of substance use disorders
Fowler, C. D., & Kenny, P. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1129-z · Cited by 27 · see citing works
Cooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 28 · see citing works
Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 26 · see citing works
The striatal cholinergic system in l-dopa-induced dyskinesias
Perez, X. A., Bordia, T., & Quik, M. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1845-9 · Cited by 24 · see citing works
Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101444 · Cited by 23 · see citing works
Self-citationLocal Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Engle, S. E., Broderick, H. J., & Drenan, R. M. (2012) · Journal of Visualized Experiments · doi:10.3791/50034 · Cited by 24 · see citing works
Self-citationAlfonso, M., Durán, R., Fajardo, D., Justo, L., & Faro, L. R. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.001 · Cited by 22 · see citing works
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 20 · see citing works
Allon, N., Chapman, S., Egoz, I., Rabinovitz, I., Kapon, J., Weissman, B. A., Yacov, G., Bloch‐Shilderman, E., & Grauer, E. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.007 · Cited by 20 · see citing works
Nagy, P. M., & Aubert, I. (2013) · Brain and Behavior · doi:10.1002/brb3.139 · Cited by 20 · see citing works
Steffensen, S. C., Shin, S. I., Nelson, A. C., Pistorius, S. S., Williams, S. B., Woodward, T. J., Park, H.-J., Friend, L. N., Gao, M., Gao, F., et al. (2017) · Addiction Biology · doi:10.1111/adb.12559 · Cited by 18 · see citing works
Self-citationBordia, T., McGregor, M., McIntosh, J. M., Drenan, R. M., & Quik, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.040 · Cited by 17 · see citing works
Self-citationAhnaou, A., Biermans, R., & Drinkenburg, W. H. I. M. (2018) · Neural Plasticity · doi:10.1155/2018/4270263 · Cited by 17 · see citing works
Corrie, L. W.-C., Stokes, C. A., Wilkerson, J. L., Carroll, F. I., McMahon, L. R., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000037 · Cited by 18 · see citing works
Rasmussen, A., Strøbæk, D., Dyhring, T., Jensen, M. L., Peters, D., Grunnet, M., Timmermann, D. B., & Ahring, P. K. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.024 · Cited by 16 · see citing works
Modulation of Gain-of-function α6*-Nicotinic Acetylcholine Receptor by β3 Subunits
Dash, B., & Lukas, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322610 · Cited by 15 · see citing works
Hoestgaard-Jensen, K., Hoestgaard-Jensen, K., & Jensen, A. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509356 · Cited by 15 · see citing works
Dash, B., Li, M. D., & Lukas, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566018 · Cited by 15 · see citing works
Breining, S. R., Melvin, M. S., Bhatti, B. S., Byrd, G. D., Kiser, M. N., Hepler, C. D., Hooker, D. N., Zhang, J., Reynolds, L. A., Benson, L. R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011299 · Cited by 15 · see citing works
A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior
Soll, L. G., Grady, S. R., Salminen, O., Marks, M. J., & Tapper, A. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.001 · Cited by 14 · see citing works
Self-citationGene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission
Peng, C., Yan, Y., Kim, V. J., Engle, S. E., Berry, J. N., McIntosh, J. M., Neve, R. L., & Drenan, R. M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13957 · Cited by 13 · see citing works
Self-citationNicotinic Acetylcholine Receptors of PC12 Cells
Mussina, K., Toktarkhanova, D., & Filchakova, O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00846-x · Cited by 14 · see citing works
Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 13 · see citing works
Kucinski, A. J., Wersinger, S. R., Stachowiak, E. K., Corso, T. D., Parry, M. J., Zhang, J., Green-Jordan, K., Letchworth, S. R., Bencherif, M., & Stachowiak, M. K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.005 · Cited by 13 · see citing works
Deletion of lynx1 reduces the function of α6* nicotinic receptors
Parker, R. L., O’Neill, H. C., Henley, B. M., Wageman, C. R., Drenan, R. M., Marks, M. J., Miwa, J. M., Grady, S. R., & Lester, H. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188715 · Cited by 14 · see citing works
Self-citationTobacco habits in nocturnal frontal lobe epilepsy
Naldi, I., Bisulli, F., Vignatelli, L., Licchetta, L., Pittau, F., Vito, L. D., Mostacci, B., Menghi, V., Provini, F., Montagna, P., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.10.014 · Cited by 14 · see citing works
Kim, S., Sohn, S., Ryu, I. S., Yang, J. H., Kim, O., Kim, J., Kim, Y., Jang, E. Y., & Choe, E. S. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac063 · Cited by 13 · see citing works
α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption
Kamens, H. M., Peck, C., Garrity, C., Gechlik, A., Jenkins, B. C., & Rajan, A. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.02.178 · Cited by 13 · see citing works
Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain
Peng, C., Engle, S. E., Yan, Y., Weera, M. M., Berry, J. N., Arvin, M. C., Zhao, G., McIntosh, J. M., Chester, J. A., & Drenan, R. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182142 · Cited by 12 · see citing works
Self-citationβ2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats
Walker, N. B., Yan, Y., Tapia, M. A., Tucker, B. R., Thomas, L. N., George, B. E., West, A. M., Marotta, C. B., Lester, H. A., Dougherty, D. A., et al. (2023) · eNeuro · doi:10.1523/eneuro.0449-22.2023 · Cited by 12 · see citing works
Self-citationChen, D.-J., Gao, F.-F., Ma, X., Shi, G.-G., Huang, Y.-B., Su, Q.-X., Sudweeks, S. N., Gao, M., Turner, D., Eaton, J. B., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.209 · Cited by 12 · see citing works
Self-citationLey, C. K.-K., Kuryatov, A., Wang, J., & Lindstrom, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103244 · Cited by 11 · see citing works
Buck, J. M., Yu, L., Knopik, V. S., & Stitzel, J. A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab138 · Cited by 11 · see citing works
Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10 · see citing works
Cardenas, A. M., Bai, Y., Heydary, Y. H., Li, J., Leslie, F. M., & Lotfipour, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063145 · Cited by 10 · see citing works
Collo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10 · see citing works
Pittel, Z., Lazar, S., Gez, R., & Chapman, S. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.11.002 · Cited by 9 · see citing works
Sandager‐Nielsen, K., Ahring, P. K., Klein, J. L., van Hout, M., Thaneshwaran, S., dos Santos, A. B., Jacobsen, T. A., Amrutkar, D. V., Peters, D., Jensen, A. A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113786 · Cited by 8 · see citing works
Striatal pathology underlies prion infection-mediated hyperactivity in mice
Gunapala, K. M., Chang, D., Hsu, C. T., Manaye, K. F., Drenan, R. M., Switzer, R. C., & Steele, A. D. (2010) · Prion · doi:10.4161/pri.4.4.13721 · Cited by 8 · see citing works
Self-citationDash, B., & Li, M. D. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-35 · Cited by 8 · see citing works
- Authors
- Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A.
- Affiliations
- California Institute of Technology (US)
- University of Colorado Boulder (US)
- University of Utah (US)
- Corresponding author
- Lester, H. A.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-07-21
- Volume
- 30
- Issue
- 29
- Pages
- 9877-9889
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3390922
- OpenAlex
- W2010309382
- Cited by
- 127
- References
- 61
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 10 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 8 · 2014: 19 · 2013: 14 · 2012: 13
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Funders
- Ellison Medical Foundation
- Gordon and Betty Moore Foundation
- Tobacco-Related Disease Research Program
- California Institute of Technology
- National Institutes of Health (5t32ns007251-22, AG033954, MH53631, GM 48677)
- National Institute on Aging (R01AG033954, AG033954)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA-19375, U19DA019375, DA 015663, DA 03194, DA17279, R01DA017279, P30DA015663, F32DA021492, R01DA003194, R01DA012242, DA12242, DA021492)
- National Institute of General Medical Sciences (P01GM048677, GM48677)
- National Institute of Neurological Disorders and Stroke (T32 NS-007251, NS007251)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotinic acetylcholine receptors, alpha4 subunit, striatal dopamine release, locomotion, burst firing, presynaptic terminals, dopaminergic neurons
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Ganglionic Stimulants, Hyperkinesis, Locomotion, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Nicotine, Receptors, Dopamine, Receptors, Nicotinic, Synaptosomes, Mice, Knockout, Dopamine Plasma Membrane Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review